Medicare Enrolled

Dr. Vinay Kapoor, M.D.

Internal Medicine · Bayside, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
22215 NORTHERN BLVD, Bayside, NY 11361
7182794005
In practice since 2006 (19 years)
NPI: 1952491698 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kapoor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kapoor? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kapoor

Dr. Vinay Kapoor is an internal medicine specialist in Bayside, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kapoor performed 4,349 Medicare services across 2,188 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kapoor received a total of $823,256 from 62 pharmaceutical and/or device companies across 1933 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kapoor is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 7% volume in NY $823,256 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,349
Medicare services
Top 7% in NY for internal medicine
2,188
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~229 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
1,095 $8 $25
Blood glucose level test
A test that measures the amount of sugar in your blood.
1,065 $4 $20
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,054 $102 $190
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
478 $75 $166
Ultrasound of arm and leg arteries
This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries.
93 $74 $350
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
92 $96 $275
Autonomic nervous system testing with heart rate response to deep breathing
This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing.
92 $81 $350
Autonomic nervous system function test
This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure.
92 $115 $450
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
62 $141 $273
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
52 $94 $262
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
35 $132 $275
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
34 $43 $143
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
28 $11 $152
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
26 $36 $100
Denosumab injection (Prolia/Xgeva) 26 $0 $1
Quadrivalent influenza vaccine, cell culture-derived
A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods.
25 $32 $82
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$823,256
Total received (2018-2024)
Avg $117,608/year across 7 years
Top 0% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
1,933
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$813,450 (98.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,681 (1.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,125 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$168,754
2023
$112,775
2022
$134,269
2021
$94,385
2020
$55,622
2019
$106,604
2018
$150,848

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$38,056
Amgen Inc.
$31,343
Boehringer Ingelheim Pharmaceuticals, Inc.
$17,190
SANOFI-AVENTIS U.S. LLC
$16,007
Bayer Healthcare Pharmaceuticals Inc.
$15,775
Dexcom, Inc.
$11,185
CeQur Corporation
$9,473
Abbott Laboratories
$8,402
Xeris Pharmaceuticals, Inc.
$7,973
Lilly USA, LLC
$7,488
Janssen Pharmaceuticals, Inc
$2,967
AstraZeneca Pharmaceuticals LP
$2,007
Amneal Pharmaceuticals LLC
$286
ABBVIE INC.
$158
Alexion Pharmaceuticals, Inc.
$86
Corcept Therapeutics
$76
Currax Pharmaceuticals LLC
$64
Mannkind Corporation
$42
Amphastar Pharmaceuticals, Inc.
$38
BETA BIONICS, INC.
$35
Antares Pharma, Inc.
$34
PFIZER INC.
$29
Tandem Diabetes Care, Inc.
$23
AIMMUNE THERAPEUTICS, INC.
$18
Top 3 companies account for 51.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$232,461
AstraZeneca Pharmaceuticals LP
$109,186
Janssen Pharmaceuticals, Inc
$93,484
Dexcom, Inc.
$55,885
Intuity Medical Inc
$49,257
SANOFI-AVENTIS U.S. LLC
$44,711
Merck Sharp & Dohme Corporation
$42,502
Abbott Laboratories
$37,099
Amgen Inc.
$32,285
Boehringer Ingelheim Pharmaceuticals, Inc.
$29,224
CeQur Corporation
$26,557
Bayer Healthcare Pharmaceuticals Inc.
$25,356
Horizon Therapeutics plc
$12,582
Xeris Pharmaceuticals, Inc.
$9,134
Lilly USA, LLC
$8,592
DEXCOM, INC.
$7,855
AbbVie, Inc.
$1,380
ARALEZ PHARMACEUTICALS US INC.
$1,125
Currax Pharmaceuticals LLC
$562
Amneal Pharmaceuticals LLC
$531
Amarin Pharma Inc.
$333
ABBVIE INC.
$330
LifeScan, Inc.
$287
Alexion Pharmaceuticals, Inc.
$275
Bayer HealthCare Pharmaceuticals Inc.
$262
Merck Sharp & Dohme LLC
$209
Corcept Therapeutics
$168
Esperion Therapeutics, Inc.
$160
Tandem Diabetes Care, Inc.
$154
GRT US Holding, Inc.
$147
Kowa Pharmaceuticals America, Inc.
$90
Althera Pharmaceuticals LLC
$83
Mannkind Corporation
$75
AbbVie Inc.
$75
MannKind Corporation
$72
Endo Pharmaceuticals Inc.
$69
Insulet Corporation
$59
Novartis Pharmaceuticals Corporation
$49
LIFESCAN, INC.
$41
Ultragenyx Pharmaceutical Inc.
$41
Amphastar Pharmaceuticals, Inc.
$38
Orexigen Therapeutics, Inc.
$37
BETA BIONICS, INC.
$35
Antares Pharma, Inc.
$34
PFIZER INC.
$29
Senseonics, Incorporated
$28
Amryt Pharma Holdings Ltd
$24
Kyowa Kirin, Inc.
$22
Ascendis Pharma Inc
$22
Allergan Inc.
$22
Intra-Sana Laboratories
$21
Hikma Pharmaceuticals USA
$21
Gemini Laboratories, LLC
$20
Nalpropion Pharmaceuticals LLC
$20
Medtronic MiniMed, Inc.
$19
AIMMUNE THERAPEUTICS, INC.
$18
Becton, Dickinson and Company
$18
Ironwood Pharmaceuticals, Inc
$17
Nalpropion Pharmaceuticals, Inc.
$16
Lexicon Pharmaceuticals, Inc.
$16
GlaxoSmithKline, LLC.
$15
Companion Medical, Inc.
$14
Top 3 companies account for 52.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AVEED · BAQSIMI · BD Ultra-Fine · BYDUREON · BYSTOLIC · CONTRAVE · CREON · CRYSViTA · CeQur Simplicity · Crysvita · Cryvista · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · Eversense · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INVOKANA · InPen · Inpefa · JANUMET · JANUVIA · JARDIANCE · Kerendia · Kloxxado · Korlym · LEQVIO · Levemir · Linzess · Livalo · MULTAQ · MYCAPSSA · Minimed 670G System · NEXLETOL · ONZETRA XSAIL · OT Verio Flex Starter Kit · OT Verio Reflect "One Touch Meter and Strips" · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · Pogo Automatic Blood Glucose Monitoring System · Prolia · Qutenza · RECORLEV · RELTONE 200 MG · RYBELSUS · Repatha · Roszet · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tresiba · UBRELVY · UNITHROID · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZENPEP · ZEPBOUND · ZONTIVITY · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (99%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in NY.

Looking for an internal medicine specialist in Bayside?
Compare internal medicine physicians in the Bayside area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
10,723
Per 100K population
460.2
County median income
$84,961
Nearest hospital
NEW YORK-PRESBYTERIAN/QUEENS
2.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kapoor is a clinical cardiology specialist, with above-average Medicare volume (top 7% in NY), with speaking/promotional industry engagement in the top 0% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kapoor experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Kapoor performed 1,095 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kapoor receive payments from pharmaceutical companies?
Yes. Dr. Kapoor received a total of $823,256 from 62 companies across 1,933 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kapoor's costs compare to other internal medicine physicians in Bayside?
Dr. Kapoor's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kapoor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →